Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2J2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,803
Award facts
- Contract value 100% obligated
- $47,803.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,803.09 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Dupixent 300 mg/2 ml pen auto-injectors. This competitive, non-set-aside award is structured as a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant indicated for moderate-to-severe atopic dermatitis, moderate-to-severe eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, making it a critical specialty pharmaceutical for military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2031 that serves as the primary sourcing mechanism for comprehensive pharmaceutical and medical supply support to military treatment facilities and veterans' healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor to federal medical procurement, with consistent competitively awarded contracts covering brand-name and generic medications, vaccines, and specialty medical supplies across multiple therapeutic domains supporting defense and civilian healthcare missions.
Quick answers
Who was awarded contract SPE2DR26FA2J2?
SPE2DR26FA2J2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FA2J2 worth?
The government has obligated $47,803 on SPE2DR26FA2J2.
Is contract SPE2DR26FA2J2 an order under another contract?
Yes. SPE2DR26FA2J2 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2J2 competed?
The extent of competition for SPE2DR26FA2J2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award